Navigation Links
Clinical Trial Treatment Offered at Sanford Granted FDA Approval
Date:6/13/2017

Sanford Health was one of several major cancer centers that participated in a groundbreaking clinical trial testing the combination of chemotherapy with immunotherapy for first-line treatment of advanced non-small cell lung cancer.

The treatment – using Keytruda, also known as pembrolizumab, in combination with pemetrexed and carboplatin – recently was granted FDA-approval through the accelerated approval program. The Keynote-021 trial enrolled 123 patients with locally advanced or metastatic non-squamous NSCLC, according to a news release from Merck, which manufactures the drug.

Key findings from the study that led to approval included nearly twice as many patients responding to the new immunotherapy combination versus standard chemotherapy (55 percent compared to 29 percent) and a longer duration of disease control. Sanford offered the trial to participants in Sioux Falls and Fargo. The study was available at 24 other major cancer centers in the United States and Taiwan. Steven Powell, M.D in Sioux Falls and Amit Panwalkar, M.D. were principal investigators on the trial. Both are medical oncologists.

“This is the new standard of care for the majority of patients with advanced lung cancer,” said Dr. Steven Powell with Sanford Health. “Our clinical trials program allowed us to bring this cutting edge option to our patients long before the FDA approval.”

Lung cancer is the No. 1 cancer killer in the United States, causing one in four cancer deaths, according to the American Cancer Society.

Sanford Health and Sanford Research continue to work toward finding innovative therapies for cancer treatment. With active research in the laboratory and through clinical trials, Sanford offers novel treatment options for many types of cancer

Updated results from the Keynote-021 trial will be presented at the American Society of Clinical Oncology conference in June. The ongoing Keynote-189 study is further evaluating this approach and was also offered at Sanford.

About Sanford Health

Sanford Health is an integrated health system headquartered in the Dakotas. It is one of the largest health systems in the nation with 45 hospitals and nearly 300 clinics in nine states and four countries. Sanford Health’s 28,000 employees, including more than 1,300 physicians, make it the largest employer in the Dakotas. Nearly $1 billion in gifts from philanthropist Denny Sanford have allowed for several initiatives, including global children's clinics, genomic medicine and specialized centers researching cures for type 1 diabetes, breast cancer and other diseases. For more information, visit sanfordhealth.org.

Read the full story at http://www.prweb.com/releases/2017/06/prweb14419336.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Dr. Esther Babady Discusses the Laboratory and Clinical Benefits of Rapid Blood Culture Diagnostics
2. Published Clinical Study Shows Capillus Laser Therapy “Safe and Effective” at Treating Female Androgenetic Alopecia
3. via seating Announces Game Changing Copper Infused Clinical Use Task Chair
4. Drs. Nicholas Rallis and Chris Chondrogiannis Celebrate 10 Years as Clinical Instructors for Prestigious NYU Full Mouth Rehabilitation CE Program
5. Medic-CE to Sponsor Live Clinical Webinar on Pediatric Septic Shock
6. Secure Video Chat Released For Diagnotes' Clinical Communication Platform
7. University of Colorado Cancer Center Clinical Trial Framework Tests ‘Natural’ Cures for Cancer
8. Mediaplanet Announces New Campaign Focusing on the Importance of Clinical Trials
9. Mediaplanet and Nonprofit Organization CISCRP Team Up for Clinical Trials Awareness and Education
10. Tony Farah, MD, Named Executive Vice President, Chief Medical and Clinical Transformation Officer for Highmark Health
11. LabRoots Presents an Educational Webinar Exploring the Clinical Relevance of Vitamin D Metabolites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance Group, a ... Miami, and Raleigh regions, is organizing an extended charity drive to benefit the ... chromosome abnormality. , After struggling since birth with several health challenges, T.J. was ...
(Date:10/13/2017)... ... 2017 , ... The International Association of Eating Disorders Professionals ... the field of eating disorders, announces the opening of early registration for the ... at the Omni Resort at ChampionsGate. , The annual iaedp™ Symposium ...
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... ... , ... Talented host, actor Rob Lowe, is introducing a ... episode of "Success Files," which is an award-winning educational program broadcasted on PBS ... in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve in ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... COPENHAGEN, Denmark , Oct. 2, 2017 The ... tool in the struggle to reverse the tide of prescription ... plan for regulating their medicine intake and stepping down their ... is set to launch in December 2017; the first 100,000 ... access. Learn more at http://www.rebound-solution.com/ ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
Breaking Medicine Technology: